INCIDENCE AND RISK FACTORS FOR ATRIAL FIBRILLATION AND ATRIAL FLUTTER IN PATIENTS WITH MULTIPLE MYELOMA AFTER MELPHALAN CONDITIONING FOR AUTOLOGOUS STEM CELL TRANSPLANT

被引：0
|
作者：
Rim, Austin [1 ]
Graiser, Michael [1 ]
Mandawat, Anant [1 ]
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2021年 / 77卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3276 / 3276
页数：1
相关论文
共 50 条
  • [31] A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplant
    Massimo Martino
    Mercedes Gori
    Giovanni Tripepi
    Anna Grazia Recchia
    Michele Cimminiello
    Pasquale Fabio Provenzano
    Virginia Naso
    Anna Ferreri
    Tiziana Moscato
    Giuseppe Console
    Barbara Loteta
    Giuseppe Alberto Gallo
    Massimo Gentile
    Vanessa Innao
    Marco Rossi
    Antonella Morabito
    Iolanda Donatella Vincelli
    Donato Mannina
    Annalisa Pitino
    [J]. Annals of Hematology, 2020, 99 : 331 - 341
  • [32] Gemcitabine, busulfan, and melphalan conditioning for autologous stem-cell transplants in multiple myeloma
    Gahrton, Gosta
    [J]. LANCET HAEMATOLOGY, 2017, 4 (06): : E250 - E251
  • [33] Factors affecting the development of atrial fibrillation and atrial flutter (AF) following autologous hematopoietic stem cell transplantation (auto-HSCT).
    Villanueva, MLH
    Loberiza, FR
    Armitage, JO
    Bociek, RG
    Ganti, AK
    Lynch, JC
    Majeed, F
    Tarantolo, SR
    Torrey, J
    Vose, JM
    Bierman, PJ
    [J]. BLOOD, 2005, 106 (11) : 498A - 498A
  • [34] BEAM Vs Melphalan Based Conditioning Therapy for Second Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma (MM)
    Veeraputhiran, Muthu
    Jain, Tania
    Deol, Abhinav
    Uberti, Joseph
    Kim, Seongho
    Dyson, Gregory
    Abidi, Muneer
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S112 - S113
  • [35] BEAM VS MELPHALAN BASED CONDITIONING THERAPY FOR SECOND AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) FOR MULTIPLE MYELOMA (MM)
    Veeraputhiran, M.
    Jain, T.
    Deol, A.
    Kim, S.
    Dyson, G.
    Uberti, J.
    Abidi, M.
    [J]. BONE MARROW TRANSPLANTATION, 2014, 49 : S347 - S348
  • [36] Busulfan and melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma
    Jung, Sung-Hoon
    Lee, Je-Jung
    Kim, Jin Seok
    Min, Chang-Ki
    Kim, Kihyun
    Choi, Yunsuk
    Eom, Hyeon-Seok
    Joo, Young Don
    Kim, Sung-Hyun
    Kwak, Jae-Yong
    Kang, Hye Jin
    Lee, Jae Hoon
    Lee, Ho Sup
    Mun, Yeung-Chul
    Moon, Joon Ho
    Sohn, Sang Kyun
    Park, Seong Kyu
    Park, Yong
    Shin, Ho-Jin
    Yoon, Sung-Soo
    [J]. BONE MARROW TRANSPLANTATION, 2018, 53 : 262 - 263
  • [37] Risk factors for the development of orthostatic hypotension during autologous stem cell transplant in patients with multiple myeloma
    Ho, Matthew
    Moscvin, Maria
    Low, Soon Khai
    Evans, Benjamin
    Close, Sara
    Schlossman, Robert
    Laubach, Jacob
    Prada, Claudia Paba
    Glotzbecker, Brett
    Richardson, Paul G.
    Bianchi, Giada
    [J]. LEUKEMIA & LYMPHOMA, 2022, 63 (10) : 2403 - 2412
  • [38] Outcomes after Autologous Stem Cell Transplant in Patients with Relapsed Multiple Myeloma
    Lemieux, Christopher
    Craig, Juliana
    Iberri, David
    Arai, Sally
    Johnston, Laura J.
    Lowsky, Robert
    Muffly, Lori S.
    Shiraz, Parveen
    Liedtke, Michaela
    Rezvani, Andrew R.
    Frank, Matthew J.
    Weng, Wen-Kai
    Meyer, Everett H.
    Shizuru, Judith A.
    Negrin, Robert S.
    Miklos, David B.
    Sidana, Surbhi
    [J]. BLOOD, 2020, 136
  • [39] Colitis in multiple myeloma patients undergoing chemotherapy and autologous stem cell transplantation: Incidence, and risk factors
    Krishna, Somashekar
    Weizhi, Zhao
    Chepyala, Pavan
    Grazziutti, Monica
    Miceli, Marisa
    Jalil, Basma A.
    Olden, Kevin W.
    Barlogie, Bart
    Anaissie, Elias
    [J]. GASTROENTEROLOGY, 2007, 132 (04) : A670 - A670
  • [40] Causes and risk factors for 30-day readmissions in patients with atrial fibrillation and atrial flutter after a cardiac ablation
    Lemor, A.
    Sud, K.
    Ahsan, S. A.
    Gholitabar, F.
    Basadre, C.
    Aziz, E.
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 : 178 - 179
12345